Drug Trial Radar · NCT07374848
Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors
Last checked: Nov 20, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
180
Planned (sponsor's estimate)
Start
Mar 2, 2026
Primary completion
Aug 2028
Study completion Sep 2029
Sponsor
- Lead sponsor
- Zai Lab (Shanghai) Co., Ltd.Industry
- Sponsor type
- Industry
- Collaborators
- Zai Lab (US) LLC
- First posted
- Jan 29, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety and tolerability of investigational study drug ZL-6201 for treating sarcoma and solid tumors cancer.
Conditions
- Solid Tumors
- Sarcomas
Interventions
ZL-6201Drug
ZL-6201 as a single-agent
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of Dose Limiting ToxicitiesTime frame: 1 cycle of study treatment (each cycle is 21 days)
- Incidence of Treatment Emergent Adverse EventsTime frame: 36 months
- Incidence of Serious adverse eventsTime frame: 36 months
- Number of participants with clinical laboratory abnormalitiesTime frame: 36 months
- Number of participants with vital sign abnormalitiesTime frame: 36 months
- Number of participants with electrocardiogram (ECG) abnormalitiesTime frame: 36 months
Locations
12 sites in 2 countries. Site status is shown where the registry gives one.
USC Norris Cancer Hospital
Los Angeles, California · Recruiting
Yale Cancer Center
New Haven, Connecticut · Recruiting
Florida Cancer Specialist
Sarasota, Florida · Recruiting
Washington University in St. Louis
St Louis, Missouri · Recruiting
Memorial Sloan-Kettering Cancer Center
Long Island City, New York · Recruiting
NYU Langone Health
New York, New York · Recruiting
Virginia Cancer Specialists
Fairfax, Virginia · Recruiting
Cancer Hospital Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, China · Recruiting
Peking University People's Hospital
Beijing, Beijing Municipality, China · Recruiting
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China · Recruiting
Shanghai East Hospital
Shanghai, Shanghai Municipality, China · Recruiting
Shanghai Sixth People's Hospital
Shanghai, Shanghai Municipality, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.